These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 20477220)

  • 1. BLP-25 liposomal vaccine: a promising potential therapy in non-small-cell lung cancer.
    Powell E; Chow LQ
    Expert Rev Respir Med; 2008 Feb; 2(1):37-45. PubMed ID: 20477220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-BLP25: a peptide vaccine strategy in non small cell lung cancer.
    Sangha R; Butts C
    Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4652-4. PubMed ID: 17671159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer.
    Butts C; Murray N; Maksymiuk A; Goss G; Marshall E; Soulières D; Cormier Y; Ellis P; Price A; Sawhney R; Davis M; Mansi J; Smith C; Vergidis D; Ellis P; MacNeil M; Palmer M
    J Clin Oncol; 2005 Sep; 23(27):6674-81. PubMed ID: 16170175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.
    Gridelli C; Rossi A; Maione P; Ferrara ML; Castaldo V; Sacco PC
    Oncologist; 2009 Sep; 14(9):909-20. PubMed ID: 19726457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with BLP25 liposome vaccine to treat non-small cell lung and prostate cancers.
    North S; Butts C
    Expert Rev Vaccines; 2005 Jun; 4(3):249-57. PubMed ID: 16026241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emepepimut-S for non-small cell lung cancer.
    Corrales-Rodriguez L; Blais N; Soulières D
    Expert Opin Biol Ther; 2011 Aug; 11(8):1091-7. PubMed ID: 21689064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of the randomized phase III trials in non-small cell lung cancer in North America.
    Kelly K
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-2-S8-5. PubMed ID: 9207308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancer.
    Socinski MA; Shea TC
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-45-S12-51. PubMed ID: 9331121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technology evaluation: BLP-25, Biomira Inc.
    Morse MA
    Curr Opin Mol Ther; 2001 Feb; 3(1):102-5. PubMed ID: 11249725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triplet chemotherapy combinations with new agents: is there a rationale?
    Bunn PA
    Semin Oncol; 1998 Aug; 25(4 Suppl 9):55-61. PubMed ID: 9728586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality therapy in the treatment of lung cancer.
    Rivera MP
    Semin Respir Crit Care Med; 2004; 25 Suppl 1():3-10. PubMed ID: 16088515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for non-small cell lung cancer: a New Zealand perspective.
    Sasidharan R; Gibbs D; Sullivan R; Simpson A; Perez D; Christmas T; McKeage M
    N Z Med J; 2006 Nov; 119(1245):U2310. PubMed ID: 17146485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined modality therapy for non-small cell lung carcinoma.
    Machtay M; Glatstein E
    Cancer J; 2002; 8 Suppl 1():S55-67. PubMed ID: 12075703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-small-cell lung carcinoma vaccines in clinical trials.
    Rossi A; Maione P; Schettino C; Bareschino MA; Sacco PC; Ambrosio R; Barbato V; Zeppa R; Palazzolo G; Gridelli C
    Expert Rev Vaccines; 2011 Jun; 10(6):887-97. PubMed ID: 21692707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neoadjuvant chemotherapy and chemoradiotherapy in locally advanced stage IIIA and IIIB of non-small-cell bronchial carcinoma (the Essen concept)].
    Eberhardt W
    Praxis (Bern 1994); 1997 Oct; 86(42):1647-53. PubMed ID: 9432686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
    Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ;
    J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of the BLP25 (MUC1 peptide) liposomal vaccine for active specific immunotherapy in stage IIIB/IV non-small-cell lung cancer.
    Palmer M; Parker J; Modi S; Butts C; Smylie M; Meikle A; Kehoe M; MacLean G; Longenecker M
    Clin Lung Cancer; 2001 Aug; 3(1):49-57; discussion 58. PubMed ID: 14656392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-BLP25 as a peptide vaccine therapy in non-small cell lung cancer: a review.
    Xia W; Wang J; Xu Y; Jiang F; Xu L
    J Thorac Dis; 2014 Oct; 6(10):1513-20. PubMed ID: 25364531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.